Conditions

Medication for Bipolar Disorder: Mania, Depression and Continuing Treatment

Understand how bipolar medication choices differ for mania, depression and maintenance, with monitoring, reproductive precautions, co-occurring substance use and shared treatment decisions.

A hand beside a medicine organizer; illustrative medication-management photograph, not identification of a specific medicine.
Illustrative medication-management photograph; not identification of a specific medicine. Photo: Laurynas Me / Unsplash.
Guide type
Conditions
Explore
Medication & Mental Health A-Z

Clinically reviewed by Dr. Sarah Boss, MD

Immediate suicidal danger, severe confusion, rapidly escalating mania or an inability to stay safe requires urgent assessment. Suspected lithium toxicity needs emergency help and no further lithium while advice is obtained. Do not independently stop a bipolar medicine because of pregnancy concerns.

Medication for bipolar disorder is chosen for a treatment phase, not simply for the diagnosis written at the top of a record. Managing mania, treating bipolar depression and reducing the risk of future episodes involve different decisions. A useful plan explains what each medicine is intended to do now, how progress will be reviewed and which parts of treatment are expected to continue when the current episode settles.

Begin with the pattern of illness

Bipolar disorder involves episodes of depression and mania or hypomania, with changes in energy, activity and sleep as well as mood. Diagnosis depends on the pattern over time. A period of unusually little need for sleep, impulsive spending or markedly increased activity is important to report even if it initially felt productive. Drug effects, thyroid illness and other conditions can complicate assessment. [1]

Bring a timeline rather than only a description of today’s symptoms. Include previous episodes, hospital treatment, medicines that helped, adverse reactions and changes associated with antidepressants or substance use. Ask whether the current diagnosis explains the full history. A careful assessment reduces the risk of treating each episode as an unrelated problem.

Medication during mania or hypomania

During mania, the priorities can include restoring safer behavior, sleep and judgment while treating the mood episode. NICE identifies antipsychotics such as haloperidol, olanzapine, quetiapine or risperidone among options, selected according to prior response, health and preferences. Lithium or other treatment may also be part of the plan. These are clinician-led choices, not instructions for selecting a medicine from a list. [2]

A prescription made during a crisis should have a clear review point. Ask what the urgent target is, what side effects to watch for and whether the same medicine is intended for longer-term treatment. The answer may change as the episode improves. Quietness or drowsiness alone should not be treated as the complete measure of recovery.

Medication during bipolar depression

Bipolar depression requires its own treatment assessment. Mood stabilizers and selected atypical antipsychotics have roles, and some people receive an antidepressant as part of a carefully considered combination. Antidepressant treatment alone can trigger mania or rapid cycling in susceptible people with bipolar disorder. Tell the prescriber about past mood elevation and do not add leftover antidepressants to manage a low period yourself. [1]

Options differ between guidelines and product authorizations. NICE discusses quetiapine and fluoxetine combined with olanzapine in certain bipolar-depression situations, with alternatives depending on existing treatment and response. This does not mean that olanzapine, fluoxetine and quetiapine can be freely exchanged or combined. The relevant medicine, formulation, age group and local authorization all need checking. [2]

Clarify whether the goal is relief from an active depressive episode or prevention of later episodes. Ask what the clinician expects to change in everyday terms: motivation, concentration, enjoyment, distress or the ability to manage basic routines. Bring concerns about emotional blunting or sedation into the same discussion rather than assuming they are unavoidable.

Continuing treatment when you feel well

Feeling stable does not automatically mean that medication is no longer needed. Bipolar disorder commonly requires long-term treatment, and a preventive prescription can have a different purpose from a short-term symptom-relief medicine. The decision should reflect the person’s episode history, recovery goals and experience of treatment rather than a fixed rule based on one good month. [1]

NICE recommends lithium as a first-line long-term medicine, while other options are considered when it is unsuitable, ineffective or poorly tolerated. The plan should explain why the selected medicine fits the person and which alternatives have been considered. Maintenance treatment still requires review; continuing indefinitely without checking benefit and adverse effects is not the same as thoughtful relapse prevention. [2]

Understand the individual medicine rather than the label

The lithium guide, lamotrigine guide and valproate guide address different practical precautions. Some antipsychotics also have phase-specific bipolar uses. A medicine described as a mood stabilizer is not necessarily suitable for every episode, and an anticonvulsant prescribed for another condition is not automatically a substitute for a bipolar treatment plan.

Keep a list that states the purpose of each medicine. Identify any treatment intended only for a short period and ask when its continuing need will be reviewed. This helps prevent a temporary prescription from becoming permanent through repeated copying, or a maintenance medicine being stopped because the original crisis has passed.

Monitoring should be part of the prescription

Tests and physical-health checks depend on the actual medicine. Lithium requires blood-level monitoring alongside kidney and thyroid assessment. Antipsychotics require attention to weight, blood pressure, glucose, lipids and movement symptoms. Valproate and other medicines have different laboratory and clinical requirements. A normal test before starting does not remove the need for later review. [2]

Ask who orders the tests, who reviews the results and how you will hear about any action. Keep the next appointment and current prescription together. When care moves between a psychiatrist, primary-care clinician and another service, request a clear handover rather than assuming that all parties can see the same record.

Lithium illness precautions and toxicity

Dehydration, substantial vomiting or diarrhea, changes in salt intake and interacting medicines can affect lithium safety. New or worsening shaking, muscle weakness, blurred vision, confusion, unusual drowsiness or difficulty speaking can indicate toxicity. Suspected toxicity is an emergency: take no further lithium while obtaining immediate medical help, and do not drive yourself. This differs from an ordinary planned reduction. [3]

Discuss illness arrangements before a problem occurs. Ask whom to contact when you cannot drink normally and make sure emergency clinicians know you take lithium. Do not use a general sick-day rule to stop and restart repeatedly without advice. The actual symptoms and recent treatment need assessment.

Pregnancy planning and reproductive health

Pregnancy, contraception and plans to conceive should be discussed early. Valproate has significant reproductive risks and specific UK safeguards, including restrictions on starting treatment and pregnancy-prevention requirements where applicable. Advice also addresses men planning conception. These requirements do not mean that every person should stop immediately; a specialist must balance the treatment, alternatives and risks of uncontrolled illness. [4]

Ask which current rules apply to your situation, because starting treatment and reviewing an established prescription are not identical. Arrange coordinated advice between psychiatric and reproductive-health clinicians. The same principle applies to other bipolar medicines: do not assume they share valproate’s risk profile, but do not label them risk-free without an individual review.

Alcohol, drugs and detox are separate care questions

Alcohol and other substances can mimic or worsen mood symptoms and may coexist with bipolar disorder. Describe actual use and recent changes, including non-prescribed sleeping tablets, stimulants and opioids. A timeline can help the clinician distinguish a mood episode, intoxication, withdrawal and an adverse effect, although more than one problem may be present. [1]

A bipolar prescription is not a home-detox regimen. Ask which professional is responsible for withdrawal assessment and how psychiatric treatment will continue during addiction care. Do not increase a mood medicine to compensate for drinking or stop it to make substance use seem safer. The alcohol withdrawal guide and opioid withdrawal guide explain the separate questions that require assessment.

Psychological treatment and daily routines

Medication can be combined with psychological treatment, education and strategies for recognizing early warning signs. Regular routines and attention to sleep can support a broader plan. These measures are not substitutes for urgent treatment when mania or depression is severe, but they give the person practical ways to participate in continuing care. [5]

Make the plan specific to your life. Discuss how work, travel, family responsibilities and financial pressures affect the routine. Agree on what you would like a trusted person to notice and how they should raise a concern. A shared plan should respect your perspective rather than making every disagreement into a symptom.

When more urgent support is needed

Immediate suicidal danger, severe confusion, rapidly escalating behavior or inability to remain safe requires urgent assessment. Some episodes need crisis-team support or hospital care. Reading a medication guide or waiting for a routine consultation should not delay necessary help. The appropriate setting depends on current clinical needs, not simply on the diagnosis or a preference for residential care. [5]

Keep contact details in an accessible place and agree how to seek help outside ordinary appointments. Explain recent medication changes and what you have actually taken. Do not attempt to control a severe episode by taking someone else’s prescription or adding unreviewed sedating medicines.

Stopping, switching and preparing for review

Do not stop bipolar medication independently because you feel better or have read about side effects. A planned change should consider previous episodes, current stability, adverse effects and the support available. It should include follow-up, not only a new dose instruction. Ask what remains unchanged and how emerging symptoms will be assessed. [5]

Prepare your main question before the appointment. Is it inadequate relief, a practical obstacle, a side effect or a wish to understand the long-term plan? Bring the medicine packets, monitoring results and a brief account of changes. The medication-review checklist can help turn a complicated history into a focused conversation.

Frequently asked questions

Is there one best bipolar medicine for everyone?

No. The treatment phase, prior response, health risks and preferences all matter. Ask why the proposed option fits the current situation.

Does improvement mean treatment can stop?

Not automatically. Preventive treatment may continue while someone feels well, with periodic review of benefit and unwanted effects. [1]

Can a family member contribute observations?

Discuss what information you want shared and how involvement would help. A clear account of changes can support the review without replacing your own priorities.

Evidence and sources

A confidential first conversation

You do not have to
work it out alone.

Ask about treatment for yourself or someone you care about. Admissions can explain the residential setting for up to four clients, the fees and the information needed for clinical review.

Your shared admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Call admissions+41 44 500 5111Email admissionsadmissions@thebalance.clinicHow admission works
COGNIFULCall
COGNIFUL

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Your admissions team

Jil Moore, Client Relations Director
Jil MooreClient Relations Director
Cynthia Nakhle, Admissions Manager
Cynthia NakhleAdmissions Manager
COGNIFUL

What would you like to explore?